Review suggests exosomes may help target multiple diabetes complications

This narrative review looks at the potential of exosomes for treating diabetic kidney disease, diabetic retinopathy, and diabetic peripheral neuropathy. The authors explore how these tiny particles could help target multiple complications at once. However, the study does not report a specific sample size or patient population because it is a review of existing concepts rather than a new trial. The text notes that current research is still working to clarify how these cells communicate across different organs in people with multiple conditions. There were no reported safety concerns or adverse events in this theoretical discussion. The main reason to be careful is that clinical standardization of exosomal biomarkers has not yet been fully developed. Readers should understand that this work may inform future strategies but is not ready for immediate clinical use. The review highlights the need to develop engineered exosomes for precision therapy before these ideas become standard practice.